Figure 5: Bioresponsive Hydrogel for PD-L1 Blockade and IDO Inhibitor Delivery.
The schematic showing the local delivery of PD-L1 blockade therapy and the IDO inhibitor, D-1MT, using a bioresponsive hydrogel. Adapted with permission from (Yu et al., 2018). Copyright 2018, John Wiley & Sons, Inc.